OPKO Health (OPK) News Today → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free OPK Stock Alerts $1.32 +0.02 (+1.54%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 6:33 AM | americanbankingnews.comPhillip Md Et Al Frost Acquires 163,997 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockMay 18 at 10:02 AM | insidertrades.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 163,997 SharesMay 18 at 3:42 AM | americanbankingnews.comOPKO Health Sees Unusually Large Options Volume (NASDAQ:OPK)May 18 at 2:29 AM | americanbankingnews.comOPKO Health (NASDAQ:OPK) Rating Increased to Sell at StockNews.comMay 17 at 7:56 PM | marketbeat.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Buys 163,997 Shares of StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 163,997 shares of OPKO Health stock in a transaction dated Friday, May 17th. The stock was purchased at an average cost of $1.29 per share, with a total value of $211,556.13. Following the completion of the purchase, the chief executive officer now owns 211,132,222 shares of the company's stock, valued at $272,360,566.38. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.May 17 at 10:54 AM | marketbeat.comInvestors Buy High Volume of OPKO Health Call Options (NASDAQ:OPK)OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw unusually large options trading on Friday. Traders bought 13,343 call options on the company. This is an increase of 114% compared to the typical daily volume of 6,244 call options.May 13, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for OPKO Health, Inc. (NASDAQ:OPK) Cut by AnalystMay 12, 2024 | americanbankingnews.comHC Wainwright Reaffirms Buy Rating for OPKO Health (NASDAQ:OPK)May 11, 2024 | americanbankingnews.comOPKO Health, Inc. to Post FY2024 Earnings of ($0.34) Per Share, Barrington Research Forecasts (NASDAQ:OPK)May 10, 2024 | marketbeat.comFY2024 EPS Estimates for OPKO Health, Inc. (NASDAQ:OPK) Cut by Barrington ResearchOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Research analysts at Barrington Research reduced their FY2024 EPS estimates for shares of OPKO Health in a research note issued to investors on Wednesday, May 8th. Barrington Research analyst M. Petusky now anticipates that the biotechnology companyMay 9, 2024 | americanbankingnews.comOPKO Health (NASDAQ:OPK) Shares Gap Down on Disappointing EarningsMay 8, 2024 | markets.businessinsider.comOpko Health Poised for Growth: Buy Rating Affirmed Amid Topline Expansion and Strategic TransactionsMay 8, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Given Buy Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $3.00 price target on shares of OPKO Health in a research note on Wednesday.May 8, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPSOPKO Health (NASDAQ:OPK - Get Free Report) released its earnings results on Tuesday. The biotechnology company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.09) by ($0.03). OPKO Health had a negative net margin of 21.76% and a negative return on equity of 12.69%. The company had revenue of $173.70 million for the quarter, compared to analyst estimates of $182.99 million. During the same quarter in the previous year, the company earned ($0.02) earnings per share. OPKO Health's revenue for the quarter was down 26.9% compared to the same quarter last year.May 7, 2024 | finance.yahoo.comOPKO Health Inc (OPK) Q1 2024 Earnings: Misses Revenue and Earnings EstimatesMay 7, 2024 | fool.comOpko Health (OPK) Q1 2024 Earnings Call TranscriptMay 7, 2024 | globenewswire.comOPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsMay 4, 2024 | marketbeat.comOPKO Health (OPK) Set to Announce Quarterly Earnings on TuesdayOPKO Health (NASDAQ:OPK) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports.May 3, 2024 | globenewswire.comOPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024April 27, 2024 | marketbeat.comPFG Investments LLC Purchases New Position in OPKO Health, Inc. (NASDAQ:OPK)PFG Investments LLC purchased a new stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 937,265 shares of the biotechnology company's stock, valued atApril 17, 2024 | marketbeat.comZacks Research Research Analysts Increase Earnings Estimates for OPKO Health, Inc. (NASDAQ:OPK)OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Research analysts at Zacks Research upped their FY2024 earnings per share estimates for shares of OPKO Health in a research note issued to investors on Monday, April 15th. Zacks Research analyst I. Bandyopadhyay now forecasts that the biotechnology cApril 17, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Trading 3.3% Higher OPKO Health (NASDAQ:OPK) Stock Price Up 3.3%April 10, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Down 7.6% OPKO Health (NASDAQ:OPK) Trading Down 7.6%April 8, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Up 5.1%OPKO Health (NASDAQ:OPK) Trading Up 5.1%April 5, 2024 | marketbeat.comHC Wainwright Analysts Cut Earnings Estimates for OPKO Health, Inc. (NASDAQ:OPK)OPKO Health, Inc. (NASDAQ:OPK - Free Report) - HC Wainwright dropped their Q2 2024 earnings estimates for OPKO Health in a research report issued to clients and investors on Wednesday, April 3rd. HC Wainwright analyst Y. Chen now expects that the biotechnology company will post earnings of ($0.09April 4, 2024 | marketbeat.comQ1 2025 Earnings Estimate for OPKO Health, Inc. (NASDAQ:OPK) Issued By HC WainwrightOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Analysts at HC Wainwright issued their Q1 2025 EPS estimates for OPKO Health in a note issued to investors on Wednesday, April 3rd. HC Wainwright analyst Y. Chen anticipates that the biotechnology company will post earnings per share of ($0.08) for tApril 3, 2024 | markets.businessinsider.comOpko Health Buy Rating Backed by Strategic Asset Sale and Promising Oral Drug CandidateApril 3, 2024 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for OPKO Health (NASDAQ:OPK)HC Wainwright reiterated a "buy" rating and issued a $3.00 price objective on shares of OPKO Health in a research report on Wednesday.April 1, 2024 | markets.businessinsider.comBuy Rating Affirmed for Opko Health Amid Strategic Divestiture and Operational Improvement ProspectsApril 1, 2024 | markets.businessinsider.comCritical Insights From OPKO Health Analyst Ratings: What You Need To KnowApril 1, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Receives "Outperform" Rating from Barrington ResearchBarrington Research reiterated an "outperform" rating and set a $1.50 price objective on shares of OPKO Health in a research report on Monday.March 29, 2024 | news.yahoo.comWho else lives on Star Island besides Diddy? Let’s look inside the South Beach enclaveMarch 28, 2024 | marketwatch.comOPKO Health Stock Rises 16% After Deal to Sell Assets to LabcorpMarch 28, 2024 | marketwatch.comLabcorp to Buy Some Lab-Testing Businesses From OPKO Health for $237.5 MillionMarch 28, 2024 | msn.comLabcorp to buy select assets from OPKO’s BioReference HealthMarch 28, 2024 | prnewswire.comLabcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessMarch 27, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Stock Price Up 7.9%OPKO Health (NASDAQ:OPK) Trading Up 7.9%March 26, 2024 | msn.comNextPlat expands North American e-commerce business with Outfitter buyMarch 25, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Sees Large Volume IncreaseOPKO Health (NASDAQ:OPK) Sees Unusually-High Trading VolumeMarch 21, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Trading Up 9%OPKO Health (NASDAQ:OPK) Shares Up 9%March 21, 2024 | marketbeat.comStock Traders Purchase Large Volume of Call Options on OPKO Health (NASDAQ:OPK)OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw some unusual options trading on Thursday. Traders purchased 31,669 call options on the company. This represents an increase of approximately 1,194% compared to the typical volume of 2,447 call options.March 21, 2024 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) to Post Q1 2024 Earnings of ($0.10) Per Share, Zacks Research ForecastsOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities researchers at Zacks Research cut their Q1 2024 EPS estimates for OPKO Health in a research note issued to investors on Tuesday, March 19th. Zacks Research analyst I. Bandyopadhyay now anticipates that the biotechnology company will post earMarch 20, 2024 | marketbeat.comAnalysts Set Expectations for OPKO Health, Inc.'s FY2026 Earnings (NASDAQ:OPK)OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Zacks Research issued their FY2026 EPS estimates for OPKO Health in a research note issued on Tuesday, March 19th. Zacks Research analyst I. Bandyopadhyay forecasts that the biotechnology company will post earnings per share of ($0.09) for the year.March 19, 2024 | insidertrades.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Buys 500,000 Shares of StockMarch 16, 2024 | investing.comOpko Health CEO Phillip Frost buys $444,300 in company stockMarch 15, 2024 | insidertrades.comPhillip Md Et Al Frost Purchases 500,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockMarch 14, 2024 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Purchases $445,000.00 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 500,000 shares of OPKO Health stock in a transaction dated Thursday, March 14th. The stock was acquired at an average cost of $0.89 per share, with a total value of $445,000.00. Following the completion of the acquisition, the chief executive officer now owns 210,468,225 shares of the company's stock, valued at $187,316,720.25. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.March 13, 2024 | insidertrades.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 600,000 SharesMarch 12, 2024 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Buys 600,000 SharesOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 600,000 shares of the stock in a transaction dated Tuesday, March 12th. The stock was purchased at an average price of $0.93 per share, with a total value of $558,000.00. Following the acquisition, the chief executive officer now owns 209,468,225 shares of the company's stock, valued at $194,805,449.25. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.March 9, 2024 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) Shares Acquired by Invesco Ltd.Invesco Ltd. grew its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 300.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,164,180 shares of the biotechnology company's stock after purch Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… OPK Media Mentions By Week OPK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPK News Sentiment▼0.270.42▲Average Medical News Sentiment OPK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPK Articles This Week▼123▲OPK Articles Average Week Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INVA News Today MNKD News Today PCRX News Today IRWD News Today LGND News Today LXRX News Today ADCT News Today AVIR News Today VNDA News Today VSTM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPK) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
